Olema Pharmaceuticals Inc

-0.76 (-2.67%)
Earnings Announcements

Olema Oncology Reports Quarterly Loss Per Share Of $0.50

Published: 03/17/2021 20:17 GMT
Olema Pharmaceuticals Inc (OLMA) - Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates.
Olema Pharmaceuticals Inc - Cash and Cash Equivalents of $338.5 Million As of December 31, 2020 Sufficient to Fund Operations Through 2022.
Olema Pharmaceuticals Inc - Qtrly Loss per Share $0.50.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.45

More details on our Analysts Page.